Understanding Mortality Among Long-Term Hodgkin Lymphoma Survivors

Contemporary treatment has resulted in 5-year relative survival rates approaching 90% for Hodgkin lymphoma (HL), making long-term survivorship an increasingly important component of clinical care. In a population-based cohort of adults with HL who survived at least 5 years after diagnosis, investigators examined both the magnitude and causes of subsequent mortality, providing insight into how the health risks facing HL survivors evolve with increasing time from diagnosis.

©2026 HMP Global. All Rights Reserved. Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.